>
Tucker shares 'backroom' info about brawl between him and Israel First crowd…
Why Isn't There a Cure for Alzheimer's Disease?
US Government Revokes 80,000 Visas
OpenAI CEO Sam Altman served legal papers during speech in dramatic on-stage ambush
Goodbye, Cavities? Scientists Just Found a Way to Regrow Tooth Enamel
Scientists Say They've Figured Out How to Transcribe Your Thoughts From an MRI Scan
SanDisk stuffed 1 TB of storage into the smallest Type-C thumb drive ever
Calling Dr. Grok. Can AI Do Better than Your Primary Physician?
HUGE 32kWh LiFePO4 DIY Battery w/ 628Ah Cells! 90 Minute Build
What Has Bitcoin Become 17 Years After Satoshi Nakamoto Published The Whitepaper?
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...

The technique could be a boon for regenerative medicine to treat neurological disorders.
Inflammation is the body's natural response to injury and damage, swelling up to allow better blood flow to the area. It also acts like a "fire alarm" to attract the attention of the immune system to help the healing process, and stem cells are some of the most important responders.
In theory, inflammation could be used to lure these regenerative stem cells to injuries, but of course there are risks. Chronic inflammation underlies conditions like arthritis, multiple sclerosis and Crohn's disease, and has even been linked to cardiovascular diseases, Alzheimer's and depression.
So for the new study, the researchers investigated ways to summon stem cells using inflammation signals without creating further inflammation. The team modified an inflammatory molecule called CXCL12, which had previously been identified as a stem cell attractor. They found that it contains two "pockets" – one that binds to stem cells and one for inflammatory signaling – so they developed a drug that maximizes the binding but minimizes the signaling.
The end result is a drug they call SDV1a, which is designed to be injected almost anywhere in the body to lure stem cells there to begin healing an injury, without causing inflammation.